Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,784 | -3,827 | -40,531 | -30,838 | -17,421 |
| Depreciation Amortization | 2,816 | 1,771 | 5,238 | 3,904 | 2,636 |
| Accounts receivable | 10,000 | N/A | -10,000 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,219 | -2,066 | 822 | 345 | -482 |
| Other Working Capital | 2,835 | 3,892 | -5,539 | -2,441 | -2,276 |
| Other Operating Activity | -7,374 | 1,657 | 15,584 | 4,449 | 1,605 |
| Operating Cash Flow | $-4,726 | $1,427 | $-34,426 | $-24,581 | $-15,938 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,000 | 2,000 | 25,571 | 9,781 | 4,865 |
| PPE Investments | 390 | N/A | -496 | -409 | -242 |
| Investing Cash Flow | $2,390 | $2,000 | $25,075 | $9,372 | $4,623 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -1,469 | N/A | N/A | N/A |
| Debt Repayment | -2,975 | N/A | -5,563 | -4,103 | -2,629 |
| Common Stock Issued | 21,782 | 21,761 | 16,145 | 16,144 | 16,145 |
| Other Financing Activity | -12,847 | -14,190 | 0 | 0 | 0 |
| Financing Cash Flow | $5,960 | $6,102 | $10,582 | $12,041 | $13,516 |
| Beginning Cash Position | 14,902 | 14,902 | 13,671 | 13,671 | 13,671 |
| End Cash Position | 18,526 | 24,431 | 14,902 | 10,503 | 15,872 |
| Net Cash Flow | $3,624 | $9,529 | $1,231 | $-3,168 | $2,201 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,726 | 1,427 | -34,426 | -24,581 | -15,938 |
| Capital Expenditure | -29 | N/A | -496 | -409 | -242 |
| Free Cash Flow | -4,755 | 1,427 | -34,922 | -24,990 | -16,180 |